{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:16:21Z","timestamp":1793297781579,"version":"4.5.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Hydroxychloroquine (HCQ) is used as a traditional disease-modifying antirheumatic drugs (DMARDs), for the treatment of autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). However, it can cause serious adverse reactions, including hyperpigmentation of the skin and bull\u2019s-eye macular lesions. Here, we present a case of HCQ-induced hyperpigmentation of the skin and bull\u2019s-eye macular lesions in a patient who received HCQ for RA. A 65-year-old female patient developed blurred vision and hyperpigmentation of multiple areas of skin over the body for one month after 3 years of HCQ treatment for RA. Based on clinical presentation, ophthalmological examination and dermatopathological biopsy, a diagnosis of drug-induced cutaneous hyperpigmentation and bullous maculopathy of the right eye was made. After discontinuation of HCQ and treatment with iguratimod tablets, the hyperpigmentation of the patient \u2018s skin was gradually reduced, and the symptoms of blurred vision were not significantly improved. We also reviewed the available literature on HCQ-induced cutaneous hyperpigmentation and bull\u2019s-eye macular lesions and described the clinical features of HCQ-induced cutaneous hyperpigmentation and bull\u2019s-eye macular lesions. In conclusion, clinicians should be aware of early cutaneous symptoms and HCQ-associated ophthalmotoxicity in patients with rheumatic diseases on HCQ sulphate and should actively monitor patients, have them undergo regular ophthalmological examinations and give appropriate treatment to prevent exacerbation of symptoms.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1383343","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T04:28:09Z","timestamp":1712723289000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Hydroxychloroquine-induced hyperpigmentation of the skin and bull\u2019s-eye maculopathy in rheumatic patients: a case report and literature review"],"prefix":"10.3389","volume":"15","author":[{"given":"Ji-peng","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-mei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-kai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-ming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv018","article-title":"Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases","volume":"70","author":"Al-Bari","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.02.056","article-title":"Immunosuppressive effect of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via regulating the differentiation of CD4+ T cell subsets in rats","volume":"70","author":"Bai","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21144972","article-title":"Immunomodulatory effects of hydroxychloroquine and chloroquine in viral infections and their potential application in retinal gene therapy","volume":"21","author":"Chandler","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4582612","article-title":"Elucidating the pivotal immunomodulatory and anti-inflammatory potentials of chloroquine and hydroxychloroquine","volume":"2020","author":"Richard","year":"2020","journal-title":"J Immunol Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012476","article-title":"Hydroxychloroquine in rheumatic autoimmune disorders and beyond","volume":"12","author":"Nirk","year":"2020","journal-title":"EMBO Mol Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac043","article-title":"When should we start screening for hydroxychloroquine retinopathy","volume":"61","author":"Alveyn","year":"2022","journal-title":"Rheumatol (Oxford England)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMicm1304542","article-title":"Hydroxychloroquine retinal toxicity","volume":"380","author":"Proano","year":"2019","journal-title":"New Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","article-title":"Age-related macular degeneration","volume":"7","author":"Fleckenstein","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuron.2012.06.018","article-title":"Mechanisms of age-related macular degeneration","volume":"75","author":"Ambati","year":"2012","journal-title":"Neuron"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00539","article-title":"C-reactive protein as a mediator of complement activation and inflammatory signaling in age-related macular degeneration","volume":"9","author":"Chirco","year":"2018","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01778","article-title":"Bruch's membrane compartmentalizes complement regulation in the eye with implications for therapeutic design in age-related macular degeneration","volume":"8","author":"Clark","year":"2017","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.4.564","article-title":"Prevalence of age-related macular degeneration in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch Ophthalmol (Chicago Ill 1960)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.03.008","article-title":"The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis","volume":"115","author":"Wong","year":"2008","journal-title":"Ophthalmology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms140612222","article-title":"UV radiation and the skin","volume":"14","author":"D'Orazio","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s13018-021-02603-2","article-title":"Effectiveness of iguratimod as monotherapy or combined therapy in patients with rheumatoid arthritis: a systematic review and meta-analysis of RCTs","volume":"16","author":"Hu","year":"2021","journal-title":"J orthopaedic Surg Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1586\/1744666x.2015.1027151","article-title":"Iguratimod for the treatment of rheumatoid arthritis in Japan","volume":"11","author":"Tanaka","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00073","article-title":"Iguratimod as a new drug for rheumatoid arthritis: current landscape","volume":"11","author":"Xie","year":"2020","journal-title":"Front Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/art.10278","article-title":"Clinical images: Hydroxychloroquine-associated mucocutaneous hyperpigmentation","volume":"46","author":"True","year":"2002","journal-title":"Arthritis rheumatism"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01412.x","article-title":"Cutaneous hyperpigmentation during therapy with hydroxychloroquine","volume":"29","author":"Millard","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01494.x","article-title":"Hydroxychloroquine-induced pigmentation in two patients with systemic lupus erythematosus","volume":"20","author":"Reynaert","year":"2006","journal-title":"J Eur Acad Dermatol Venereology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/01.rhu.0000260649.36417.09","article-title":"Cutaneous hyperpigmentation during therapy with hydroxychloroquine","volume":"13","author":"Amichai","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/jcp.2008.33.issue-6","article-title":"Hydroxychloroquine-induced hyperpigmentation: a case report","volume":"33","author":"Melikoglu","year":"2008","journal-title":"J Clin Pharm Ther"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2008.01004.x","article-title":"Hydroxychloroquine-induced hyperpigmentation: the staining pattern","volume":"35","author":"Puri","year":"2008","journal-title":"J cutaneous Pathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/03009740701769735","article-title":"Hyperpigmentation of the skin due to hydroxychloroquine","volume":"37","author":"Rood","year":"2008","journal-title":"Scandinavian J Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5070\/D32T07Q0NW","article-title":"Persistent cutaneous hyperpigmentation due to hydroxychloroquinone one year after therapy discontinuation","volume":"15","author":"Morrison","year":"2009","journal-title":"Dermatol Online J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2012.01591.x","article-title":"Hydroxychloroquine-induced hyperpigmentation","volume":"39","author":"Cho","year":"2012","journal-title":"J Dermatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"20723","DOI":"10.5070\/D31912020723","article-title":"Hydroxycholoroquine-induced hyperpigmentation","volume":"19","author":"Mir","year":"2013","journal-title":"Dermatol Online J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-013-0032-z","article-title":"Hydroxychloroquine-associated hyperpigmentation mimicking elder abuse","volume":"3","author":"Cohen","year":"2013","journal-title":"Dermatol Ther"},{"key":"B30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/RHU.0b013e31829d547b","article-title":"Hydroxychloroquine-induced hyperpigmentation","volume":"19","author":"Tracy","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140995","article-title":"Hydroxychloroquine-induced hyperpigmentation of the skin","volume":"42","author":"Sawalha","year":"2015","journal-title":"J Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.150622","article-title":"Hydroxychloroquine-related skin discoloration","volume":"189","author":"Coulombe","year":"2017","journal-title":"CMAJ Can Med Assoc J"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-227305","article-title":"Woman in grey: hydroxychloroquine-induced hyperpigmentation","volume":"11","author":"Ivo","year":"2018","journal-title":"BMJ Case Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2018-136377","article-title":"Hydroxychloroquine induced cutaneous pigmentation: a unique pattern","volume":"95","author":"Thakur","year":"2019","journal-title":"Postgraduate Med J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2017.10.006","article-title":"Drug-associated hyperpigmentation of the oral mucosa: report of four cases","volume":"125","author":"Tosios","year":"2018","journal-title":"Oral surgery Oral medicine Oral Pathol Oral Radiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2018.17190","article-title":"A case of exogenous ochronosis associated with hydroxychloroquine","volume":"5","author":"Tekg\u00f6z","year":"2018","journal-title":"Eur J Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(67)92518-4","article-title":"Ocular changes induced by long-term hydroxychloroquine (plaquenil) therapy","volume":"64","author":"Shearer","year":"1967","journal-title":"Am J Ophthalmol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(87)90005-5","article-title":"Hydroxychloroquine therapy in massive total doses without retinal toxicity","volume":"104","author":"Johnson","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(14)76853-9","article-title":"Hydroxychloroquine retinopathy","volume":"112","author":"Weiner","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/01.iae.0000226540.61840.d7","article-title":"Optical coherence tomography findings in hydroxychloroquine and chloroquine-associated maculopathy","volume":"1","author":"Fung","year":"2007","journal-title":"Retinal cases Brief Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s10633-010-9220-7","article-title":"Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up","volume":"120","author":"Salu","year":"2010","journal-title":"Documenta ophthalmologica Adv Ophthalmol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1097\/icb.0000000000000006","article-title":"Hydroxychloroquine retinopathy after short-term therapy","volume":"8","author":"Phillips","year":"2014","journal-title":"Retinal Cases Brief Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2147\/opth.S76963","article-title":"Near-infrared reflectance bull's eye maculopathy as an early indication of hydroxychloroquine toxicity","volume":"9","author":"Wong","year":"2015","journal-title":"Clin Ophthalmol (Auckland NZ)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10633-015-9521-y","article-title":"A possible early sign of hydroxychloroquine macular toxicity","volume":"132","author":"Brandao","year":"2016","journal-title":"Documenta Ophthalmologica Adv Ophthalmol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1056\/NEJMicm1412167","article-title":"Bull's-eye maculopathy associated with hydroxychloroquine","volume":"380","author":"Modi","year":"2019","journal-title":"New Engl J Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(19)30040-2","article-title":"Hydroxychloroquine-induced bull's eye maculopathy","volume":"2","author":"Pellerano","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s12886-022-02657-8","article-title":"Early onset monocular hydroxychloroquine maculopathy in a systemic lupus erythematosus patient with history of central retinal artery occlusion: a case report","volume":"22","author":"Ameen Ismail","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1945.s1-25.469","article-title":"Pigmentation of the palate and subungual tissues associated with suppressive quinacrine hydrochloride therapy","volume":"25","author":"Lippard","year":"1945","journal-title":"Am J Trop Med hygiene"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3109\/15569527.2010.521225","article-title":"Antimalarial cutaneous side effects: a study in 209 users","volume":"30","author":"Skare","year":"2011","journal-title":"Cutaneous Ocular Toxicol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.709","article-title":"Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study","volume":"149","author":"Jallouli","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2014.3459","article-title":"The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy","volume":"132","author":"Melles","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58070967","article-title":"Extreme interocular asymmetry in an atypical case of a hydroxychloroquine-related retinopathy","volume":"58","author":"Hallali","year":"2022","journal-title":"Medicina (Kaunas Lithuania)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1383343\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T04:28:12Z","timestamp":1712723292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1383343\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2024.1383343"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1383343","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,10]]},"article-number":"1383343"}}